✦ LIBER ✦

C34 THE ROLE OF ADJUVANT INTRAVESICAL BCG THERAPY FOR MEDIUM/HIGH RISK NON-INVASIVE BLADDER TUMOURS

✍ Scribed by Gluck, G.; Chirita, M.M.; Stoica, R.; Daia, D.; Sinescu, I.

Book ID: 123494420
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 279 KB
Volume: 11
Category: Article
ISSN: 1569-9056
DOI: 10.1016/S1569-9056(13)60036-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Contemporary management of patients with

Contemporary management of patients with high-risk non-muscle-invasive bladder cancer who fail intravesical BCG therapy

✍ D. R. Yates; M. Rouprêt 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 197 KB

PCN11 COST EFFECTIVENESS OF ADJUVANT, IN

PCN11 COST EFFECTIVENESS OF ADJUVANT, INTRAVESICAL THERAPY FOR NON-INVASIVE TRANSITIONAL CELL CARCINOMA OF THE BLADDER

✍ M Kerrigan; SD Ramsey; D Penson; DK Blough; L Garrison 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB

1783 LONG-TERM OUTCOMES OF ELECTRO-MOTIV

1783 LONG-TERM OUTCOMES OF ELECTRO-MOTIVE DRUG ADMINISTRATION OF MITOMYCIN-C AFTER FAILED INTRAVESICAL BCG IMMUNOTHERAPY IN HIGH RISK, NON-MUSCLE INVASIVE TRANSITIONAL CELL CARCINOMA OF THE BLADDER

✍ Crawford, Ruairidh; Wright, Hannah; Borwell, Jonathan; Parker, Theresa; Montgome 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 49 KB

The novel use of intravesical docetaxel

The novel use of intravesical docetaxel for the treatment of non-muscle invasive bladder cancer refractory to BCG therapy: a single institution experience

✍ LaMont J. Barlow; James M. McKiernan; Mitchell C. Benson 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 237 KB

1786 A PROSPECTIVE COMPARATIVE STUDY OF

1786 A PROSPECTIVE COMPARATIVE STUDY OF INTRAVESICAL BACILLUS CALMETTE-GUERIN (BCG) THERAPY WITH THE TOKYO OR CONNAUGHT STRAINS FOR NON-MUSCLE INVASIVE BLADDER CANCER

✍ Sengiku, Atsushi; Ito, Masaaki; Miyazaki, Yu; Sawazaki, Harutake; Takahashi, Tak 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 53 KB

647 WHAT IS THE LONG TERM PROGNOSTIC VAL

647 WHAT IS THE LONG TERM PROGNOSTIC VALUE OF PROAPOPTOTIC, ANTI-APOPTOTIC, PROLIFERATION AND INVASIVENESS MOLECULAR MARKERS IN PATIENTS TREATED WITH BCG FOR HIGH RISK NON-INVASIVE BLADDER CANCER?

✍ S.S. Alkhateeb; M.G. Neill; B.W. Van Rhijn; D. Kakiashvili; N.E. Fleshner; M.A.S 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 505 KB